Our Pricing

Saxenda vs Mounjaro: Choose Your Weight Loss Treatment

Choosing between Saxenda vs Mounjaro UK prescription treatments can feel overwhelming when both are proven weight loss injections. At Cured Pharmacy, our UK-registered clinical team helps you understand the key differences in mechanism, efficacy, dosing frequency, and cost so you can make an informed decision with your prescriber.

How Saxenda and Mounjaro Work Differently

Saxenda contains liraglutide, a GLP-1 receptor agonist that mimics a natural gut hormone to reduce appetite and slow gastric emptying [1]. It's been licensed in the UK since 2015 and requires daily subcutaneous injections, making it a well-established option for adults with a BMI of 30 or above, or 27 with weight-related health conditions.

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management [2]. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, tirzepatide produces more significant weight loss outcomes than single-pathway treatments. It's administered once weekly, offering greater convenience than daily injections.

The dual-action mechanism of Mounjaro has demonstrated superior efficacy in head-to-head comparisons. In the SURPASS-2 trial, patients on tirzepatide 15mg achieved an average 12.4kg weight loss compared to 6.2kg with semaglutide 1mg over 40 weeks [2]. This represents a clinically meaningful difference for patients seeking maximum weight reduction.

Clinical Efficacy: Saxenda vs Mounjaro Weight Loss Results

In the SCALE Obesity and Prediabetes trial, patients using Saxenda 3mg daily achieved an average weight loss of 8% of their initial body weight over 56 weeks, compared to 2.6% with placebo [1]. Approximately 63% of participants lost at least 5% of their body weight, meeting the clinical threshold for meaningful health benefits.

Mounjaro has demonstrated substantially higher efficacy across multiple trials. In the SURMOUNT-1 study, participants on the highest dose (15mg weekly) achieved an average 22.5% body weight reduction over 72 weeks [3]. Even the lowest maintenance dose of 5mg produced average weight loss of 15%, exceeding Saxenda's outcomes at maximum dosing.

These differences reflect the enhanced metabolic effects of dual GIP/GLP-1 receptor activation. Patients seeking the most significant weight reduction may find Mounjaro offers superior results, though individual responses vary and both medications require adherence to a reduced-calorie diet and increased physical activity for optimal outcomes.

Real-World Effectiveness

Clinical trial results represent ideal conditions with close monitoring and support. In real-world UK pharmacy practice, our superintendent pharmacist Tarun Kumar observes that patient adherence significantly influences outcomes with both treatments. Daily Saxenda injections require consistent routine, while weekly Mounjaro dosing may improve compliance for patients with busy schedules or needle anxiety.

Dosing, Administration and Convenience

Saxenda requires daily subcutaneous injections, typically administered at the same time each day regardless of meals. Treatment begins at 0.6mg daily and increases weekly until reaching the maintenance dose of 3mg, allowing your body to adjust gradually and minimising gastrointestinal side effects [1]. Each pre-filled pen lasts approximately 6 days at the full 3mg dose.

Mounjaro is administered once weekly on the same day each week, offering significantly greater convenience. The starting dose is 2.5mg weekly for four weeks, then increases to 5mg. Your UK prescriber may further increase the dose in 2.5mg increments every four weeks up to a maximum of 15mg weekly, based on your weight loss response and tolerability [2]. Each KwikPen contains four weekly doses.

Both medications use similar injection techniques with small, thin needles designed for subcutaneous administration into the abdomen, thigh, or upper arm. Patients who've used both treatments often report that weekly injections fit more easily into their lifestyle than daily dosing, though individual preferences vary.

Storage and Handling Requirements

Both Saxenda and Mounjaro require refrigeration between 2°C and 8°C before first use. Once in use, Saxenda pens can be stored at room temperature (below 30°C) for up to 30 days, while Mounjaro pens may be kept at room temperature for up to 21 days. Always protect both medications from direct light and never freeze them, as freezing destroys their active ingredients.

Side Effects and Safety Considerations

The most common side effects of both Saxenda and Mounjaro are gastrointestinal: nausea, diarrhoea, constipation, vomiting, and abdominal discomfort [1][2]. These symptoms typically occur when starting treatment or increasing doses, and often diminish over several weeks as your body adjusts. Taking your injection after a light meal may help reduce nausea.

Mounjaro's dual-receptor mechanism can produce more pronounced gastrointestinal effects initially, particularly at higher doses. In SURMOUNT-1, nausea occurred in approximately 29% of participants on tirzepatide 15mg compared to 12% on placebo [3]. However, discontinuation rates due to adverse events remained relatively low at around 6%, suggesting most patients tolerate the medication with appropriate dose escalation.

Both medications carry warnings about potential thyroid C-cell tumours based on rodent studies, though no causal relationship has been established in humans [1][2]. They're contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will assess your medical history during consultation to ensure either treatment is appropriate for you.

Cost Comparison: Saxenda vs Mounjaro UK Pricing

At Cured Pharmacy, Saxenda starts from £135.00 per pen, with pricing varying based on your prescribed quantity and treatment duration. Because Saxenda requires daily injections, monthly costs reflect the need for approximately five pens to maintain the 3mg daily dose throughout a typical month.

Mounjaro starts from £135.00 per KwikPen at Cured Pharmacy, with each pen containing four weekly doses. This represents one month's treatment when used at any maintenance dose from 2.5mg to 15mg weekly, as the pen delivers your prescribed dose four times regardless of strength. The once-weekly dosing schedule means you're purchasing monthly rather than every six days.

When comparing overall treatment costs, consider both the medication price and the dosing frequency. While Saxenda has a lower per-pen price, the daily administration requirement means purchasing more frequently. Mounjaro's higher upfront cost covers a full month of weekly injections. Your UK prescriber will discuss the most cost-effective option based on your clinical needs and budget during your free consultation.

NHS and Private Prescription Options

Both Saxenda and Mounjaro are available on private prescription in the UK through registered pharmacies like Cured Pharmacy. NHS prescription availability is limited and subject to strict eligibility criteria set by NICE guidelines, typically requiring specialist referral through tier 3 weight management services. Most UK patients access these treatments privately to avoid lengthy waiting times and restrictive qualifying conditions.

Making Your Choice: Which Treatment Suits You?

Your decision between Saxenda and Mounjaro should consider several factors beyond just efficacy data. If you're seeking maximum weight loss and clinical trials suggest you may benefit from more significant reduction, Mounjaro's superior outcomes in head-to-head studies make it worth discussing with your prescriber [3]. However, if you prefer a well-established treatment with over eight years of UK licensing history and a lower starting price, Saxenda remains an excellent evidence-based option.

Lifestyle factors matter considerably. Patients who travel frequently, work irregular hours, or simply prefer less frequent injections often find Mounjaro's weekly schedule more manageable than Saxenda's daily requirement. Conversely, some patients feel more in control with daily dosing, appreciating the regular routine and immediate ability to pause treatment if needed.

Medical history plays a crucial role in determining suitability. Patients with a history of pancreatitis, severe gastrointestinal disease, or certain thyroid conditions may not be suitable candidates for either medication [1][2]. Your UK prescriber will review your complete medical history, current medications, and weight loss goals during your online consultation to recommend the most appropriate treatment. At Cured Pharmacy, you'll receive personalised clinical advice from our GPhC-registered team, not a one-size-fits-all approach.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and weight loss outcomes depend on adherence to a reduced-calorie diet and increased physical activity alongside medication use.